Two Sigma Advisers’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Sell |
38,838
-418,780
| -92% | -$4.71M | ﹤0.01% | 1809 |
|
|
2025
Q1 | $2.61M | Sell |
457,618
-283,500
| -38% | -$1.62M | 0.01% | 1049 |
|
|
2024
Q4 | $7.28M | Sell |
741,118
-66,100
| -8% | -$649K | 0.02% | 574 |
|
|
2024
Q3 | $6.58M | Buy |
807,218
+21,129
| +3% | +$172K | 0.02% | 619 |
|
|
2024
Q2 | $10.5M | Buy |
786,089
+757,813
| +2,680% | +$10.1M | 0.02% | 524 |
|
|
2024
Q1 | $1.31M | Buy |
28,276
+9,452
| +50% | +$439K | ﹤0.01% | 1443 |
|
|
2023
Q4 | $1.27M | Buy |
18,824
+14,705
| +357% | +$994K | ﹤0.01% | 1525 |
|
|
2023
Q3 | $298K | Sell |
4,119
-1,870
| -31% | -$135K | ﹤0.01% | 1980 |
|
|
2023
Q2 | $446K | Buy |
5,989
+533
| +10% | +$39.7K | ﹤0.01% | 1852 |
|
|
2023
Q1 | $290K | Buy |
5,456
+3,477
| +176% | +$185K | ﹤0.01% | 2148 |
|
|
2022
Q4 | $134K | Buy |
+1,979
| New | +$134K | ﹤0.01% | 2255 |
|